How to Buy Arrivent Biopharma Stock

Arrivent Biopharma Inc

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Arrivent Biopharma stock last closed at $19.54, up 7.72% from the previous day, and has increased 22.89% in one year. It has overperformed other stocks in the Biotechnology industry by 1 percentage points. Arrivent Biopharma stock is currently +36.17% from its 52-week low of $14.35, and -46.27% from its 52-week high of $36.37.

There are currently 34.02M AVBP shares outstanding. The market value of AVBP is $664.68M. In the last 24 hours, 202,616 AVBP shares were traded.

How to Buy Arrivent Biopharma Stock

Not sure how to invest in Arrivent Biopharma stock? Here's how.

  1. Choose where to buy Arrivent Biopharma stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Arrivent Biopharma stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Select your method of payment and add your info.
  4. Evaluate Arrivent Biopharma stock: The Arrivent Biopharma ticker symbol is AVBP. Is Arrivent Biopharma stock a good investment? Should you buy shares of AVBP? How do AVBP's underlying business fundamentals look? Do top analysts think Arrivent Biopharma is a good buy? Why has AVBP's stock price moved recently? (Hint: Our stock research tools can help you understand if AVBP is a good stock to buy).
  5. Place your AVBP buy order: Decide if you will purchase AVBP shares at the current market price or use a limit order to purchase AVBP shares at a specific price.
  6. Keep tabs on your AVBP investment: Create a watchlist to monitor your investment in Arrivent Biopharma stock.

Step 1: Choose where to buy Arrivent Biopharma stock

You need an online brokerage account to access the NASDAQ market and buy AVBP shares.

A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've selected the right brokerage, you need to fill out some personal information so you can buy AVBP today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to start your new trading account.
  1. Send your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've opened your account on a good stock buying app, you can securely and quickly fund your account:

Watch the tutorial below for more details transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Arrivent Biopharma stock

After you have decided on the best place to buy Arrivent Biopharma stock, it's critical to evaluate their stock before you buy, so you truly understand the risk as well as the opportunity.

Arrivent Biopharma shares data

AVBP Price
$19.54
1w %
6.28%
1y %
22.89%
5y %
N/A
P/E
-7.63x
P/B
2.58x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$80.49M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$664.68M
Next Earnings
N/A
Next Dividend
N/A

AVBP Due Diligence Checks

WallStreetZen was built to help everyday investors do more accurate fundamental analysis in less time.

You can view all of the due diligence checks on AVBP's stock page.

Is AVBP stock overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge AVBP's intrinsic value.

Using relative valuations measures:

  • AVBP could be undervalued based on its P/B ratio of 2.58x, relative to Biotechnology industry P/B ratio of 4.04x

You can do additional valuation analysis on AVBP's stock here.

AVBP Financial Health Summary

Positive Financial Indicators:

  • AVBP has a low debt to equity ratio of 0.07.
  • AVBP has cash burn of 70212000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the AVBP balance sheet.
  • There are more short-term assets than long-term liabilities on the AVBP balance sheet.
  • AVBP has $218.86M in cash and short term investments. This is sufficient to cover its annual cash burn of $70.21M.

Do Wall Street analysts think it's a good time to buy Arrivent Biopharma stock

Out of 3 Equities analysts who give forecasts on AVBP, the consensus analyst rating on Arrivent Biopharma is a Strong Buy

Please note that analyst forecasts are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Arrivent Biopharma stock forecast page.

AVBP Technicals

SMA10
17.81
SMA20
18.05
SMA50
21.39
SMA100
24.33
SMA200
24.85
MACD
-0.77
MACD Signal
-1.2
MACD Histogram
0.43
RSI
52.98
Stochastic %K
80.49
Stochastic %D
78.54
StochRSI %K
90.96
StochRSI %D
92.05

Latest Insiders Trades at AVBP

Over the last year, executives and large shareholders at AVBP have bought more shares than they have sold.

Robin Lachapelle, Chief Operating Officer of AVBP, was the latest AVBP insider to buy. They bought $45,128.60 worth of AVBP shares on Sep 19, 2024.

Research more about who owns AVBP stock here.

Does AVBP provide a stable income stream?

No, Arrivent Biopharma doesn't provide an income stream by paying out dividends.

Get opinions from other traders

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your AVBP buy order

You have two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually fine for most investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given dollar amount limit, use a limit order.

Click the Open button and your broker will execute your order.

If you want additional info about buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your AVBP investment

Now that you own some AVBP shares, you'll want to stay up-to-date on your investment.

Add AVBP to a watchlist to track the latest developments regarding your AVBP stock.

AVBP Feed

How to Buy Stock in Arrivent Biopharma

To summarize, here are the 6 steps for buying Arrivent Biopharma stock:

  1. Choose where to buy Arrivent Biopharma stock
  2. Sign up for your brokerage account
  3. Fund your brokerage account
  4. Evaluate Arrivent Biopharma stock
  5. Place your AVBP buy order
  6. Keep tabs on your AVBP investment

If you are looking for a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest scoop on your investment in Arrivent Biopharma, get started below.

NASDAQ: AVBP
$19.54+1.40 (+7.72%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: AVBP
$19.54+1.40 (+7.72%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Arrivent Biopharma share?

As of Apr 21, 2025, it costs $19.54 to buy one share of Arrivent Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.461 shares of AVBP.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Arrivent Biopharma stock?

According to 3 Wall Street analysts who monitor Arrivent Biopharma, their consensus recommendation is to buy Arrivent Biopharma stock.

What is the best way to buy Arrivent Biopharma stock?

One way to place an order for Arrivent Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.